Shopping Cart
- Remove All
- Your shopping cart is currently empty
Brazikumab (AMG 139), a human IgG2 monoclonal antibody, selectively targets the p19 subunit of IL-23 with a dissociation constant (K D) of 0.138 nM, indicating high affinity for human IL-23. It is employed in Crohn's disease research [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $247 | 7-10 days | |
5 mg | $645 | 7-10 days | |
10 mg | $987 | 7-10 days | |
25 mg | $1,530 | 7-10 days | |
50 mg | $1,980 | 7-10 days | |
100 mg | $2,790 | 7-10 days |
Description | Brazikumab (AMG 139), a human IgG2 monoclonal antibody, selectively targets the p19 subunit of IL-23 with a dissociation constant (K D) of 0.138 nM, indicating high affinity for human IL-23. It is employed in Crohn's disease research [1]. |
Cas No. | 1610353-18-8 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.